Parameter | PDGFR-α negative | PDGFR-α positive | P |
---|---|---|---|
PDGF-A | |||
Negative | 19 (52.7%) | 2 (16.7%) | |
Positive | 17 (47.3%) | 10 (83.3%) | 0.0290 |
Age (n) | 56.315 ± 11.913 (108) | 52.986 ± 12.811 (70) | NS (0.0788) |
Tumour size, mm (n) | 31.406 ± 22.056 (106) | 30.101 ± 22.655 (69) | NS (0.7057) |
Histological grade | |||
I | 20 (19.4%) | 9 (12.8%) | |
II | 38 (36.9%) | 34 (48.6%) | |
III | 45 (43.7%) | 27 (38.6%) | NS (0.2595) |
Axillary lymph node status | |||
Negative | 47 (48%) | 18 (27.3%) | |
Positive | 51 (52%) | 48 (72.7%) | 0.0079 |
Oestrogen receptor status | |||
Negative | 30 (27.8%) | 19 (26.7%) | |
Positive | 78 (72.2%) | 52 (73.3%) | NS (0.8813) |
p53 | |||
Negative | 38 (54.3%) | 21 (53.8%) | |
Positive | 32 (45.7%) | 18 (46.2%) | NS (0.9648) |
MIB-1 (n) | 19.449 ± 17.484 (49) | 12.333 ± 12.584 (15) | NS (0.1491) |
HER-2 | |||
Negative (0/1+) | 54 (57.4%) | 26 (40%) | |
2+ | 17 (18.1%) | 10 (15.4%) | |
3+ | 23 (24.5%) | 29 (44.6%) | 0.0265 |
Bcl2 | |||
Negative | 29 (59.2%) | 15 (33.3%) | |
Positive | 20 (40.8%) | 30 (66.7%) | 0.0121 |
Angiogenesis index (n) | 43.393 ± 26.498 (55) | 43.633 ± 27.635 (18) | NS (0.9737) |
Patient survival, months (n) | 24.917 ± 19.500 (48) | 21.067 ± 20.405 (15) | NS (0.5115) |